0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-07-23 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 15855251 2024-07-23 2025-07-31 15855251 2025-07-31 15855251 2024-07-22 15855251 bus:Director1 2024-07-23 2025-07-31 15855251 core:WithinOneYear 2025-07-31 15855251 core:ShareCapital 2025-07-31 15855251 core:RetainedEarningsAccumulatedLosses 2025-07-31 15855251 bus:SmallEntities 2024-07-23 2025-07-31 15855251 bus:AuditExempt-NoAccountantsReport 2024-07-23 2025-07-31 15855251 bus:SmallCompaniesRegimeForAccounts 2024-07-23 2025-07-31 15855251 bus:PrivateLimitedCompanyLtd 2024-07-23 2025-07-31 15855251 bus:FullAccounts 2024-07-23 2025-07-31
COMPANY REGISTRATION NUMBER: 15855251

Clinix Ultrasound Diagnostics Ltd

Filleted Unaudited Financial Statements

31 July 2025

Clinix Ultrasound Diagnostics Ltd

Statement of Financial Position

31 July 2025

| 31 Jul 25
Note | £

Current assets

Cash at bank and in hand | 1,887

Creditors: amounts falling due within one year | 4 | 875
| -------
Net current assets | 1,012
| -------
Total assets less current liabilities | 1,012
| -------
Net assets | 1,012
| -------

Capital and reserves

Called up share capital | 2
Profit and loss account | 1,010
| -------
Shareholders funds | 1,012
| -------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 20 April 2026 , and are signed on behalf of the board by:

Mr T J Eze |
Director |

Company registration number: 15855251

Clinix Ultrasound Diagnostics Ltd

Notes to the Financial Statements

Period from 23 July 2024 to 31 July 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 117 Foster Road, Trumpington, Cambridge, Cambridgeshire, CB2 9JW, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Creditors: amounts falling due within one year

| 31 Jul 25
| £
Corporation tax | 237
Other creditors | 638
| ----
| 875
| ----

5. Controlling party
The company is controlled Mr T J Eze , who holds 50% of the issued share capital and voting rights and has the power to appoint and remove directors. Dr C H Umeh holds the remaining 50% of the issued share capital and voting rights, but does not have the ability to exercise overall control of the company.